Clinical trial · Observational
Biological Sample Collection for Research and Biobanking
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): The study was voluntarily terminated by the PI to focus efforts on an alternative biobanking protocol.
Summary
Brief summary (as posted)
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to study different conditions and diseases by using cells from the body (such as skin or blood cells). NYSCF uses these samples to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and/or store these samples for future use. Through this research, scientists hope to identify future treatments or even cures.
Conditions
Conditions (7)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| ALS | — | UNRESOLVED | — |
| Alzheimer Disease | — | UNRESOLVED | — |
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Diabetes Mellitus, Type 1 | — | UNRESOLVED | — |
| Huntington Disease | — | UNRESOLVED | — |
| Macular Degeneration | — | UNRESOLVED | — |
| Parkinson Disease | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Biological sample collection | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Establishment of a diverse bank of biological samples, stem cell lines, derivatives, and associated information.
- timeFrame
- Baseline
- description
- There are no primary endpoints planned for this biobank; endpoints will be specific to research projects that utilize samples/data contained in the biobank. Projects may investigate the biology, etiology, manifestations, progression, risk factors, genetic underpinnings, and treatment of diseases, conditions, and traits.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Month
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: Age * 18 years or older or * Minor with parent/guardian consent Biological Sample Collection * Able and willing to provide: * new samples of blood, skin, and/or saliva specifically for use in this study and/or * excess/leftover samples, cell lines, and/or derivatives that were (or will be) collected for reasons other than this study Exclusion Criteria: * Non-English speaking * Wards of the state * For skin samples collected specifically for this study: history of keloid formation, bleeding disorder, allergy to the anesthetic, or anticoagulation use that precludes sample collection. * For blood samples collected specifically for this study: bleeding disorder, or other medical condition, if the subject's condition increases the risks associated with blood collection. * For saliva samples: inability to produce sufficient saliva or has a condition that precludes sample collection (such as severe trismus). * For prospective samples: refuse to adhere to NYSCF's and/or collaborating site's COVID-19 safety protocols during the COVID-19 pandemic.
References
Publications (0)
Data not yet available